Triiodothyronine (T3) has been shown to augment the therapeutic effect of tricyclic antidepressants as well as monoamine oxidase inhibitors. In this report, three cases of T3 potentiation of the antidepressant effect of fluoxetine are described. The results suggest that T3 augmentation may be effective with a wide range of antidepressants.
References
1.
ExteinIL, GoldMS. Thyroid hormone potentiation of tricyclic antidepressants. In: ExteinIL, ed. Treatment of tricyclic-resistant depression.Washington DC: American Psychiatric Press, Inc., 1989: 1–27.
2.
JoffeRT. Triiodothyronine potentiation of the antidepressant effect of phenalzine. J Clin Psychiatry1988; 49: 409–410.
3.
DebusJR, RushAJ, HimmelC, Fluoxetine versus trazodone in the treatment of outpatients with major depression. J Clin Psychiatry1988; 49: 422–426.
4.
WhybrowPC, PrangeAJJr. A hypothesis of thyroid-catecholamine-receptor interaction. Arch Gen Psychiatry1981; 38: 106–113.
